CLVT
Next earnings: Jul 29, 2026 · Before open
Signal
Bearish Setup2
Price
1
Move-1.42%Negative session
Volume
1
Volume0.5× avgLight volume
Technical
1
RSIRSI 49Momentum negative
PRICE
Prev Close
2.81
Open
2.84
Day Range2.73 – 2.84
2.73
2.84
52W Range1.66 – 4.77
1.66
4.77
36% of range
VOLUME & SIZE
Avg Volume
5.5M
FUNDAMENTALS
P/E Ratio
-13.2x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.34
Market-like
Performance
1D
-1.42%
5D
-2.12%
1M
+11.69%
3M
+33.17%
6M
-20.40%
YTD
-17.07%
1Y
-35.28%
Best: 3M (+33.17%)Worst: 1Y (-35.28%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
67% gross margin
Valuation
FAIR
P/E not available
Health
WEAK
CR 0.8 (low) · FCF $0.93/sh
Neutral
Key MetricsTTM
Market Cap$1.77B
Revenue TTM$2.45B
Net Income TTM-$137.40M
Free Cash Flow$597.10M
Gross Margin66.5%
Net Margin-5.6%
Operating Margin5.0%
Return on Equity-2.8%
Return on Assets-1.3%
Debt / Equity0.91
Current Ratio0.84
EPS TTM$-0.21

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
1 strong5 concern
20/100
Liquidity
0.84Concern
Leverage
0.91Strong
Coverage
0.5xConcern
ROE
-2.8%Concern
ROIC
1.3%Concern
Cash
$329MConcern
ANALYST COVERAGE19 analysts
HOLD
+19.1%upside to target
L $3.00
Med $3.30consensus
H $3.60
Buy
526%
Hold
1053%
Sell
421%
5 Buy (26%)10 Hold (53%)4 Sell (21%)
Full report →
Stock Health
Composite Score
1 of 5 signals bullish
3/10
Technicals
RSI RangeRSI 49 — Bearish momentum
Volume
Volume FlowDistribution — institutional selling
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusHold
~
LiquidityCurrent Ratio 0.84 — liquidity risk
Upcoming Events
EEarnings Report · Before OpenMay 7, 2026
Tomorrow
DEx-Dividend DateAug 4, 2026
In 90 days
PDividend PaymentAug 10, 2026
In 96 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

DowntrendDeath Cross · 50D trails 200D by 8.2%

-11.9% vs SMA 50 · -19.2% vs SMA 200

Momentum

RSI48.8
Neutral territory
MACD-0.10
Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$4.77+72.2%
EMA 200
$3.42+23.5%
EMA 50
$3.04+9.6%
Current
$2.77
52W Low
$1.66-40.1%
52-Week RangeMid-range
$1.6636th %ile$4.77
Squeeze SetupVolume-based
Distribution Pressure

Distribution pattern detected. More selling days than accumulation over the past 20 sessions. Not a conducive environment for a squeeze.

20-Day Money Flow
Acc days:5
Dist days:2
Edge:+3 acc
Volume Context
Avg Vol (50D)5.3M
Recent Vol (5D)
4.3M-19%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 7 analysts
Analyst revisions:Revenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$2.6B
$2.6B$2.7B
-$1.91
±2%
High5
FY2024
$2.6B
$2.5B$2.6B
-1.9%$0.73
±3%
High7
FY2025
$2.4B
$2.4B$2.5B
-4.4%$0.66-9.3%
±2%
High7
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryCLVT
Last 8Q
+12.4%avg beat
Beat 6 of 8 quarters Estimates falling
+11%
Q3'24
Q4'24
+5%
Q1'25
+17%
Q2'25
Q3'25
+12%
Q4'25
+25%
Q1'26
+29%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
Goldman SachsNeutral
Jan 8
DOWNGRADE
Morgan StanleyEqual-Weight → Underweight
Dec 17
DOWNGRADE
BarclaysUnderweight
Sep 8
DOWNGRADE
Morgan StanleyEqual-Weight
Feb 6
DOWNGRADE
Insider Activity
SEC Filings →
5 Buys/1 SellNet Buying
Veinstein BarPresident, A&G
$1.2M
Dec 1
SELL
Cornick Kenneth L.Dir
$345K
Nov 10
BUY
Cornick Kenneth L.Dir
$792K
Nov 3
BUY
Cornick Kenneth L.Dir
$1.7M
Oct 31
BUY
Snyder Andrew MilesDir
$4.9M
Oct 31
BUY
Cornick Kenneth L.Dir
$617K
Aug 1
BUY
Financials

INSTITUTIONAL OWNERSHIP

1
UBS Group AG
8.8M
2
BW Gestao de Investimentos Ltda.
5.9M
3
Bank of New York Mellon Corp
1.8M
4
IRIDIAN ASSET MANAGEMENT LLC/CT
1.8M
5
Nuveen, LLC
1.0M
6
WOLVERINE ASSET MANAGEMENT LLC
608K
7
CenterBook Partners LP
547K
8
Robeco Institutional Asset Management B.V.
420K
News & Activity

CLVT News

20 articles · 4h ago

About

clarivate analytics is the global leader in providing trusted insights and analytics to accelerate the pace of innovation. we offer some of the most trusted brands across the innovation lifecycle, including web of science™, cortellis™, derwent™, compumark™, markmonitor® and techstreet™. organizations and researchers rely on the curated knowledge bases from clarivate for information about scientific and academic research, patent analytics, pharmaceutical and biotech intelligence and ip management. an independent company with over 4,000 employees and operations in more than 100 countries, clarivate is on a bold entrepreneurial mission to help radically reduce the time from new ideas to life-changing innovations. for more information, please visit clarivate.com.

CEO
Jonathan Gear
Country
United Kingdom
Tabita AnderssonSenior Vice President of Communications & Brand
Bar VeinsteinPresident of Academia & Government
Maroun S. MouradPresident of Intellectual Property
Peers(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
CLVT
$2.77-1.42%$1.8B-397.0%-819.1%1500
$394.41-1.79%$2.0T30.2+3296.8%4510.0%1500
$132.26-0.76%$307.0B23.5+586.3%1305.9%1500
$87.40-3.03%$300.4B13.3+318.8%1510.7%1500
$181.24-1.21%$281.0B26.8+862.9%1745.9%1500
$145.50+0.61%$277.6B20.6+597.3%2564.4%1500
$89.71+0.50%$254.0B14.5-591.0%668.4%1500
Sector avg-1.01%21.5+667.7%1640.9%1500